| P50 | author | Stanley M Lemon | Q89119633 |
| | Geoffrey W McCaughan | Q93355454 |
| | Francis Bodola | Q122901780 |
| P2093 | author name string | Teh-Sheng Chan | |
| | Jiaren Sun | |
| | Patrick Bertolino | |
| | David G Bowen | |
| | Hong Diao | |
| | Junhui Jia | |
| | Batbayar Tumurbaatar | |
| | Wendell Tang | |
| P2860 | cites work | Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1 | Q24653515 |
| | Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus | Q27469800 |
| | DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection | Q27469850 |
| | Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease | Q27473001 |
| | Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection | Q27473003 |
| | Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection | Q27485119 |
| | Generalized lacZ expression with the ROSA26 Cre reporter strain | Q27860837 |
| | Determinants of viral clearance and persistence during acute hepatitis C virus infection | Q28131757 |
| | Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis | Q29619627 |
| | Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse | Q29620355 |
| | Interleukin-12 in the treatment of chronic hepatitis B and C. | Q53883948 |
| | Cytokine-dependent bystander hepatitis due to intrahepatic murine CD8+ T-cell activation by bone marrow–derived cells | Q59564548 |
| | DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope | Q73709103 |
| | Antigen-specific primary activation of CD8+ T cells within the liver | Q73785320 |
| | Antigen presentation by liver cells controls intrahepatic T cell trapping, whereas bone marrow-derived cells preferentially promote intrahepatic T cell apoptosis | Q74147805 |
| | Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival | Q74251688 |
| | Immunomodulatory effects of the liver: deletion of activated CD4+ effector cells and suppression of IFN-gamma-producing cells after intravenous protein immunization | Q74650514 |
| | Autoimmunity without diabetes in transgenic mice expressing beta cell-specific CD86, but not CD80: parameters that trigger progression to diabetes | Q77186054 |
| | Selective retention of activated CD8+ T cells by the normal liver | Q78224776 |
| | The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice | Q29620765 |
| | HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help | Q29620766 |
| | Hepatitis C virus core and envelope proteins do not suppress the host's ability to clear a hepatic viral infection | Q33869825 |
| | Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes | Q34048667 |
| | The chimpanzee model of hepatitis C virus infections | Q34282817 |
| | Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites | Q34323105 |
| | Cre-stimulated recombination at loxP-containing DNA sequences placed into the mammalian genome | Q34544449 |
| | Hepatic T cells and liver tolerance | Q35038298 |
| | Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice | Q35383976 |
| | Site-specific recombination mediated by an adenovirus vector expressing the Cre recombinase protein: a molecular switch for control of gene expression | Q35843809 |
| | The immunologic basis for hepatitis C infection. | Q36036675 |
| | Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. | Q36310768 |
| | Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells | Q36371359 |
| | Cytotoxic T lymphocytes derived from patients with chronic hepatitis C virus infection kill bystander cells via Fas-FasL interaction | Q36959209 |
| | The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity | Q37486636 |
| | IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines | Q38289507 |
| | Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. | Q38973017 |
| | Nuclear targeting determinants of the phage P1 cre DNA recombinase | Q39729797 |
| | Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype. | Q39878719 |
| | Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase | Q40396045 |
| | Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus | Q40588817 |
| | Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. | Q40777376 |
| | MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. | Q41664847 |
| | Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase | Q41735303 |
| | Efficient conditional transgene expression in hepatitis C virus cDNA transgenic mice mediated by the Cre/loxP system | Q42987308 |
| | Expression of co-stimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology | Q42988418 |
| | Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders | Q42997948 |
| | Possible role of cytotoxic T cells in acute liver injury in hepatitis C virus cDNA transgenic mice mediated by Cre/loxP system | Q43000750 |
| | Failure to infect rhesus monkeys with hepatitis C virus strains of genotypes 1a, 2a or 3a. | Q43031832 |
| | Characterization of the immune response against hepatitis C infection in recovered, and chronically infected chimpanzees | Q43040977 |
| | Combined interferon alpha2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial | Q43047961 |
| | Lack of susceptibility of various primates and woodchucks to hepatitis C virus | Q43049121 |
| | Harm, ethics committees and the gene therapy death | Q43077649 |
| | Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo | Q43687301 |
| | A tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver | Q43974818 |
| | DNA synthesis in isolated hepatocytes infected with herpesviruses | Q43991445 |
| | Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon | Q44860628 |
| | B7/BB-1 expression and hepatitis activity in liver tissues of patients with chronic hepatitis C. | Q45163605 |
| | Viral escape and T cell exhaustion in hepatitis C virus infection analysed using Class I peptide tetramers | Q45729543 |
| | Indispensable role for TNF-alpha and IFN-gamma at the effector phase of liver injury mediated by Th1 cells specific to hepatitis B virus surface antigen. | Q45741755 |
| | Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity | Q45764886 |
| | Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. | Q45861628 |
| | Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure | Q45869678 |
| | Coexpression of B7-1 and viral ("self") transgenes in pancreatic beta cells can break peripheral ignorance and lead to spontaneous autoimmune diabetes | Q46495737 |
| | ELISPOT assay to measure antigen-specific murine CD8(+) T cell responses | Q47882518 |
| | Antigen-specific T cell activation and proliferation during oral tolerance induction. | Q52034130 |
| P433 | issue | 16 | |
| P921 | main subject | virology | Q7215 |
| | Hepatitis C virus | Q708693 |
| P304 | page(s) | 10730-10739 | |
| P577 | publication date | 2005-08-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Parenchymal expression of CD86/B7.2 contributes to hepatitis C virus-related liver injury | |
| P478 | volume | 79 | |